Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.855
-0.065 (-2.23%)
At close: Jun 24, 2026, 4:00 PM EDT
2.850
-0.005 (-0.18%)
After-hours: Jun 24, 2026, 4:10 PM EDT
Genelux Market Cap
Genelux has a market cap or net worth of $126.79 million as of June 24, 2026. Its market cap has increased by 25.42% in one year.
Market Cap
126.79M
Enterprise Value
102.85M
1-Year Change
25.42%
Ranking
Category
Stock Price
$2.86
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $126.79M, a decrease of -10.52%. That is a compound annual growth rate of -3.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 126.79M | -22.70% |
| Dec 31, 2025 | 164.02M | 103.78% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NRx Pharmaceuticals | 137.55M |
| Pyxis Oncology | 136.85M |
| Connect Biopharma Holdings | 134.11M |
| Coya Therapeutics | 127.14M |
| Spero Therapeutics | 127.09M |
| Jyong Biotech | 126.20M |
| PepGen | 125.89M |
| Agenus | 124.93M |